The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...
The FDA has approved Rybrevant in combination with carboplatin and pemetrexed for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer ...
Information about the poll methodology, demographics of the respondents and a map of the geographic regions for this week’s Star Tribune/MPR News/KARE 11 Minnesota Poll.
Key secondary endpoints were mPR (no viable tumor cells in tumor specimen and ≤10% residual viable tumor cells in lymph nodes) and feasibility of surgery. Across the three treatment arms, 72.1% to ...
Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...